[F2] Flash Talk (Even no.)

4:59 PM - 5:00 PM JST(7:59 AM - 8:00 AM UTC)R&D IIIImmunology

[F2-20] Isolation of a novel high-avidity TCR in pancreatic cancer patients treated with the combination of gemcitabine and WT1₁₂₆ peptide vaccine

*Soyoko Morimoto^1,3, Sumiyuki Nishida^2,3, Fumihiro Fujiki⁴, Atsushi Kumanogoh^2,3, Haruo Sugiyama⁵ (1. Department of Cancer Stem Cell Biology, Graduate School of Medicine, The University of Osaka (Japan), 2. Department of Respiratory Medicine and Clinical Immunology, Graduate School of Medicine, The University of Osaka (Japan), 3. Center for Advanced Modalities and Drug Delivery System, The University of Osaka (Japan), 4. Department of Cancer Immunotherapy, Graduate School of Medicine, The University of Osaka (Japan), 5. Department of Cancer Immunology, Graduate School of Medicine, The University of Osaka (Japan))

Password required to view

Log in

or